Heidelberg Pharma (Germany) Performance
| HPHA Stock | EUR 2.46 0.09 3.53% |
Heidelberg Pharma has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.064, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Heidelberg Pharma are expected to decrease at a much lower rate. During the bear market, Heidelberg Pharma is likely to outperform the market. Heidelberg Pharma right now retains a risk of 2.92%. Please check out Heidelberg Pharma downside deviation, information ratio, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Heidelberg Pharma will be following its current trending patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Heidelberg Pharma AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Heidelberg Pharma is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 5 M | |
| Free Cash Flow | -28 M |
Heidelberg |
Heidelberg Pharma Relative Risk vs. Return Landscape
If you would invest 242.00 in Heidelberg Pharma AG on December 13, 2024 and sell it today you would earn a total of 4.00 from holding Heidelberg Pharma AG or generate 1.65% return on investment over 90 days. Heidelberg Pharma AG is generating 0.0686% of daily returns and assumes 2.9241% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Heidelberg, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Heidelberg Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heidelberg Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Heidelberg Pharma AG, and traders can use it to determine the average amount a Heidelberg Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0234
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | HPHA | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.92 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Heidelberg Pharma is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Heidelberg Pharma by adding it to a well-diversified portfolio.
Heidelberg Pharma Fundamentals Growth
Heidelberg Stock prices reflect investors' perceptions of the future prospects and financial health of Heidelberg Pharma, and Heidelberg Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Heidelberg Stock performance.
| Current Valuation | 194.72 M | |||
| Price To Book | 24.79 X | |||
| Price To Sales | 12.52 X | |||
| Revenue | 1.75 M | |||
| EBITDA | (24.84 M) | |||
| Cash Flow From Operations | (26.61 M) | |||
| Total Asset | 21.73 M | |||
About Heidelberg Pharma Performance
By analyzing Heidelberg Pharma's fundamental ratios, stakeholders can gain valuable insights into Heidelberg Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Heidelberg Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Heidelberg Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Heidelberg Pharma performance evaluation
Checking the ongoing alerts about Heidelberg Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Heidelberg Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Heidelberg Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.75 M. Net Loss for the year was (26.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heidelberg Pharma generates negative cash flow from operations |
- Analyzing Heidelberg Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Heidelberg Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Heidelberg Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Heidelberg Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Heidelberg Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Heidelberg Pharma's stock. These opinions can provide insight into Heidelberg Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Heidelberg Stock analysis
When running Heidelberg Pharma's price analysis, check to measure Heidelberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heidelberg Pharma is operating at the current time. Most of Heidelberg Pharma's value examination focuses on studying past and present price action to predict the probability of Heidelberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heidelberg Pharma's price. Additionally, you may evaluate how the addition of Heidelberg Pharma to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |